Organizations Filed Purposes:
Immunotherapy Foundations (IF) initial mission is to find an effective treatment, and ultimately a cure for HPV-related cancers through the partnering and funding of research, studies and revolutionary treatments broadly known as immunotherapy. This research falls under the following three broad immunotherapy categories: adoptive cell therapies, immune response vaccines, and novel drugs.All projects will be designed to bring promising human therapies to the clinic. The projects will address the biology of HPV-related cancers, particularly those of the head and neck. The current research shows promise to extend to other malignancies. The projects are tightly interconnected to leverage information, allowing efficient movement into the clinic.
Our cause is to fund the following programs and studies:A cutting-edge cancer mutanome focused personalized immunotherapy program.A novel immune therapy for head and neck squamous cell carcinoma (HNSCC) that lays the framework for developing drugs, antibodies, and vaccines against cancers.Identification of a novel immune biomarker in the RNA sequence that allows us to predict and assess a patients response to immunotherapy.A robust clinical trial portfolio of immunotherapies for patients with HPV-related cancers, stressing studies with novel therapies, translational research, and biomarker discovery.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Christina B Jordan | Executive Dir. | 40 | $83,077 |
| Margaux C Stack-Babich | MANAGER | 40 | $70,578 |
| Christina A Martine | Executive Dir. | 40 | $65,169 |
| Randy Woods | Secretary | 1 | $0 |
| Mark Minasian | Treasurer | 1 | $0 |
| Fernanda L Whitworth | President | 20 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202023219349321817_public.xml